Country for PR: United States
Contributor: PR Newswire New York
Wednesday, September 13 2017 - 22:00
Premium Tissue Processor Provides Pathology Labs a High Level of Specimen Safety with Traceability
NUSSLOCH, Germany, Sept. 13, 2017 /PRNewswire-AsiaNet/ --

Leica Biosystems today announced the addition of the HistoCore PELORIS 3 
Premium Tissue Processor  [ 
] to its full line of histology equipment and consumables. HistoCore PELORIS 3 
introduces unique track and trace features to provide traceability and 
accountability, while delivering high quality tissue processing and an enhanced 
user experience.

Photo - 

"We are very excited to introduce traceability and accountability into tissue 
processing with the HistoCore PELORIS 3," stated Peter Reimer, Vice President 
of Core Histology of Leica Biosystems. "Through feedback from our customers, we 
have developed a tissue processor that is truly designed for the user. I am 
confident that our solution will help enhance the high quality standards 
required in the lab."

HistoCore PELORIS 3 is the world's first tissue processor incorporating an 
easy-to-use solution for track and trace. The integrated bar code scanner and 
on-board reporting module associate the samples with the processing program, 
reagent details and user information. This helps eliminate manual records, 
while providing a higher level of specimen safety with traceability.

Two built-in density meters reduce potential errors in reagent exchanges and 
allow for better reproducibility. This innovative "smart" feature monitors 
reagent status and alerts the user of incorrect concentrations to protect the 
integrity of the tissue.

New user-friendly features include a 12.1 inch (30.73 cm) color touch screen 
with smooth workflow navigation, LED back lit bottles for better visibility, a 
convenient wax scraper, liquid level sensor tool, a redesigned basket with 
integrated handle for increased stability, and wedges on the retort lid to 
provide secure basket placement.

In addition, HistoCore PELORIS 3 maintains market leading capabilities, 
including ActivFlo technology for rapid and conventional processing, while 
providing the productivity to accommodate up to 600 cassettes via the patented 
dual retort design. 

About Leica Biosystems
Leica Biosystems is a global leader in workflow solutions and automation. As 
the only company to own the workflow from biopsy to diagnosis, we are uniquely 
positioned to break down the barriers between each of these steps.  Our mission 
of "Advancing Cancer Diagnostics, Improving Lives" is at the heart of our 
corporate culture. Our easy-to-use and consistently reliable offerings help 
improve workflow efficiency and diagnostic confidence. The company is 
represented in over 100 countries. It has manufacturing facilities in 9 
countries, sales and service organizations in 19 countries, and an 
international network of dealers. The company is headquartered in Nussloch, 
Germany. Visit for more information. 

Media Contact: 
Courtney Hill, Global Brand Marketing Specialist 
Phone: +1.847.405.7041

95.14748 Rev A

SOURCE:  Leica Biosystems